This review demonstrates cancer treatment benefits of reactive oxygen species using metal-organic frameworks, indicating their therapeutic promise.
Reactive oxygen species (ROS) hold significant therapeutic potential in cancer treatment, with metal-organic framework (MOF)-based nanocarriers showing considerable promise for ROS-mediated therapies. This review systematically explored the advantages of MOFs...
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: